# Intrathecal Administration of Baclofen (ITB) to Cerebral Palsy Patients With Therapy-Resistant Spasticity

> **NCT00221611** · PHASE2 · COMPLETED · sponsor: **University Hospital, Ghent** · enrollment: 80 (—)

## Conditions studied

- Cerebral Palsy

## Interventions

- **DRUG:** Administration of intrathecal baclofen

## Key facts

- **NCT ID:** NCT00221611
- **Lead sponsor:** University Hospital, Ghent
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-01
- **Primary completion:** —
- **Final completion:** 2006-08
- **Target enrollment:** 80 (—)
- **Last updated:** 2007-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00221611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00221611, "Intrathecal Administration of Baclofen (ITB) to Cerebral Palsy Patients With Therapy-Resistant Spasticity". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00221611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*